Endothelium in CAD |
||||||
Friday, 12 April 2002 |
||||||
Organizer |
O. Gurné (Brussels, Belgium) J.L. Balligand (Brussels, Belgium) |
|||||
Endothelium in coronary artery disease |
||||||
Session I |
Abstract no
|
|||||
| Chair | O. Gurné (Brussels, Belgium) | |||||
| 9.30 – 9.55 |
Molecular regulation of e-NOS by the endothelium J.L. Balligand (Brussels, Belgium) |
|||||
| 9.55 – 10.20 |
Regulation of cardiac contraction by e-NOS and beta3 adrenoceptors S. Moniotte (Brussels, Belgium) |
|||||
| 10.20 – 10.45 |
Transfection e-NOS in coronary arteries S. Janssens (Leuven, Belgium) |
|||||
| 10.45 – 11.15 | coffee break | |||||
| Chair | J.L. Balligand (Brussels, Belgium) | |||||
| 11.15 – 11.45 |
Drug therapy of endothelial dysfunction O. Gurné (Brussels, Belgium) |
|||||
| 11.45 – 12.15 |
Effect of Irbesartan on microcirculation in hypertensive patients with Metabolic Syndrome X O.Timar, E. Levy, J. Buithieu, M. Bachand, J-L. Chiasson, and F. Sestier (Quebec, Canada) |
|||||
| 12.15 – 12.30 | discussion and final remarks |
78
|
||||
| 12.30 | end of workshop 6 | |||||
